Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard F Anderson

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
JAMA Health Forum|August 17, 2022
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019Elizabeth Plummer, Mariana P Socal, Jeromie M Ballreich, et al.
The Milbank Quarterly|November 23, 2021
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care ProgramAditi P Sen, Yashaswini Singh, Mark K Meiselbach, et al.
Medical Care|May 29, 2004
Chronic medical illness, depression, and use of acute medical services among Medicare beneficiariesSeth Himelhoch, Wendy E Weller, Albert W Wu, et al.
Pharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
International Orthopaedics|July 19, 2020
Economic implications of decreased elective orthopaedic and musculoskeletal surgery volume during the coronavirus disease 2019 pandemicMatthew J Best, Keith T Aziz, Edward G McFarland, et al.
Health Affairs Scholar|July 28, 2025
Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023Ilina C Odouard, So-Yeon Kang, Jessica Mo, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|August 28, 2020
Naming Convention, Interchangeability, and Patient Interest in BiosimilarsMariana P Socal, Jace B Garrett, William B Tayler, et al.
Pharmacoeconomics|November 9, 2020
Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"William V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Journal of Cataract and Refractive Surgery|December 13, 2003
Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: report of the International Cataract Surgery Outcomes StudyJens Christian Norregaard, Peter Bernth-Petersen, Jordi Alonso, et al.
JAMA Internal Medicine|April 26, 2021
Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured PatientsAditi P Sen, Mark K Meiselbach, Yang Wang, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
JAMA Health Forum|August 17, 2022
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019Elizabeth Plummer, Mariana P Socal, Jeromie M Ballreich, et al.
The Milbank Quarterly|November 23, 2021
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care ProgramAditi P Sen, Yashaswini Singh, Mark K Meiselbach, et al.
Medical Care|May 29, 2004
Chronic medical illness, depression, and use of acute medical services among Medicare beneficiariesSeth Himelhoch, Wendy E Weller, Albert W Wu, et al.
Pharmacoeconomics|June 14, 2020
Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the USWilliam V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
International Orthopaedics|July 19, 2020
Economic implications of decreased elective orthopaedic and musculoskeletal surgery volume during the coronavirus disease 2019 pandemicMatthew J Best, Keith T Aziz, Edward G McFarland, et al.
Health Affairs Scholar|July 28, 2025
Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023Ilina C Odouard, So-Yeon Kang, Jessica Mo, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|August 28, 2020
Naming Convention, Interchangeability, and Patient Interest in BiosimilarsMariana P Socal, Jace B Garrett, William B Tayler, et al.
Pharmacoeconomics|November 9, 2020
Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"William V Padula, Sonal Parasrampuria, Mariana P Socal, et al.
Journal of Cataract and Refractive Surgery|December 13, 2003
Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: report of the International Cataract Surgery Outcomes StudyJens Christian Norregaard, Peter Bernth-Petersen, Jordi Alonso, et al.
JAMA Internal Medicine|April 26, 2021
Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured PatientsAditi P Sen, Mark K Meiselbach, Yang Wang, et al.
Pageof 17